Indoximod

Indoximod is an indolyl carboxylic acid. Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others. Indoximod is a methylated tryptophan with immune checkpoint inhibitory activity. Indoximod inhibits the enzyme indoleamine 2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, and may increase or maintain tryptophan levels important to T cell function. Tryptophan depletion is associated with immunosuppression involving T cell arrest and anergy. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include D-1-methyltryptophan and indoximodum. Its PubChem CID is 405012.

CAS No 110117-83-4
Molecular Formula C12H14N2O2
Molecular Weight 218.25 g/mol
Synonyms (2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid

Frequently Asked Questions